Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teprasiran for Prophylaxis of Delayed Graft Function in Kidney Transplant
NCT00802347Phase 2Completed
- Sponsor
- Quark Pharmaceuticals
- Start
- Dec 2008
- Primary completion
- Nov 2013
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 5
01
Overview
A Phase 2 trial of teprasiran in delayed graft function (DGF), sponsored by Quark Pharmaceuticals. Started Dec 2008; status: completed.
02
Drugs
teprasiran
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT00802347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802347.